Verified Nov 2026
Batteries & E-Mobility
·
Westminster, Colorado
·
Since 2009
TriSalus Life Sciences is a publicly listed oncology therapeutics company headquartered in Westminster, Colorado, United States, and founded in 2009. It employs roughly 100 to 200 people and reported revenue in the $45.2 million band. The company develops drug delivery and immunotherapy products for liver and pancreatic tumors, serving interventional radiologists and medical oncologists in the healthcare sector. Its TriNav Infusion System is FDA-cleared for hepatic arterial infusion, and in September 2026 it received FDA clearance for TriNav Advance, expanding its pressure-enabled drug delivery portfolio for liver embolization.
TriSalus Life Sciences at a glance
Revenue
45.2M
Employees
100-200
Founded
2009
Headquarters
Westminster, Colorado
Ownership
Publicly traded (NASDAQ: TLSI)
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Plumbing & Hardware
Industrial Equipment
STABILITY SIGNALS
Established & strong
17 years in operation (founded 2009).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
TriSalus Life Sciences is a publicly listed oncology therapeutics company headquartered in Westminster, Colorado, United States, and founded in 2009. It employs roughly 100 to 200 people and reported revenue in the $45.2 million band. The company develops drug delivery and immunotherapy products for liver and pancreatic tumors, serving interventional radiologists and medical oncologists in the healthcare sector. Its TriNav Infusion System is FDA-cleared for hepatic arterial infusion, and in September 2026 it received FDA clearance for TriNav Advance, expanding its pressure-enabled drug delivery portfolio for liver embolization.
At a glance
Attribute | Detail |
|---|---|
Founded | 2009 |
Headquarters | Westminster, Colorado |
Employees | 100-200 |
Revenue | 45.2M |
Ownership | Publicly traded (NASDAQ: TLSI) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 |
What TriSalus Life Sciences makes
The company's products include the TriNav Infusion System and Pressure-Enabled Drug Delivery infusion systems, and it holds ISO 13485 certification for its medical device quality management.
Certifications
TriSalus Life Sciences is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — cobioscience.com
Latest developments
2026-10-12 — Full Transcript: TriSalus Life Sciences Q2 2026… - SquawkNews (squawknews.com)
2026-09-22 — TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization (businesswire.com)
2026-08-17 — TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference (marketbeat.com)
2026-05-12 — TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth (businesswire.com)
2026-05-04 — TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors (businesswire.com)
2025-06-04 — TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System (businesswire.com)
Company details
TriSalus is publicly listed under the ticker TLSI, with a market capitalization of approximately $226 million and around 110 employees according to its profile. TriSalus Life Sciences was founded in 2009, has an estimated 100-200 employees, and is headquartered in Westminster, Colorado. On the LightSource stability read it is rated "Established & strong": 17 years in operation (founded 2009). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does TriSalus Life Sciences make?
TriSalus Life Sciences is a publicly listed oncology therapeutics company headquartered in Westminster, Colorado, United States, and founded in 2009. It employs roughly 100 to 200 people and reported revenue in the $45.2 million band. The company develops drug delivery and immunotherapy products for liver and pancreatic tumors, serving interventional radiologists and medical oncologists in the healthcare sector. Its TriNav Infusion System is FDA-cleared for hepatic arterial infusion, and in September 2026 it received FDA clearance for TriNav Advance, expanding its pressure-enabled drug delivery portfolio for liver embolization.
Where is TriSalus Life Sciences headquartered?
TriSalus Life Sciences is headquartered in Westminster, Colorado (6272 W 91st Ave, Westminster, Colorado, 80031).
When was TriSalus Life Sciences founded?
TriSalus Life Sciences was founded in 2009.
How big is TriSalus Life Sciences?
TriSalus Life Sciences has an estimated 100-200 employees, with revenue in the 45.2M range.
Is TriSalus Life Sciences publicly traded?
Publicly traded (NASDAQ: TLSI). Public financial figures are drawn from its filings.
What certifications does TriSalus Life Sciences hold?
TriSalus Life Sciences lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.